Search Results 971-980 of 16947 for Amphotericin B
... B cell malignancies by engineering T cells to recognize B cell specific tumor markers; however, attempts to treat solid tumors with CAR T-cells have ...
1 cells administered following a conditioning lymphodepletion regimen in diffuse large B cell lymphoma (DLBCL) subjects who failed at least two lines of therapy ...
May Elbanna, M.B., B.Ch., Ph.D. Radiation Oncologist. Rochester, MN. Areas of focus: Proton therapy, Radiation therapy ...
Inclusion Criteria are the following: age ≥ 18, blood cancer diagnosis (including B-ALL, multiple myeloma, and lymphoma), receiving a CAR-T product, able ...
... B-cell lymphoma 2 (BCL2) inhibitor. A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma.
May Elbanna, M.B., B.Ch., Ph.D. Radiation Oncologist. Rochester, MN ...
Patients with active hepatitis B (chronic or acute; defined as having a positive hepatitis B surface antigen [HBsAg] test at screening) or hepatitis C:.
Medicina (B Aires). 2004; 64: (4)357-67. View PubMed; Benzo R, Sahn SA. Fever, pleuritic chest pain, and a lung ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.